Michelle Linterman is Programme Leader at the Malaghan Institute (Aotearoa New Zealand) and an Associate Group Leader at Babraham Institute (United Kingdom). Her laboratory’s research focus is on how different cell types collaborate in the germinal centre to generate a robust antibody response following vaccination and infection. Her team’s work combines research in mice, with human studies to enable us to deliver mechanistic insight into the germinal centre response that is of direct relevance to human health.